Appraising efficacy of existing and advanced technologies for the remediation of beta-blockers from wastewater: A review

被引:7
|
作者
Ahmad, Azhan [1 ]
Priyadarshini, Monali [2 ]
Raj, Rishabh [2 ]
Das, Sovik [1 ]
Ghangrekar, Makarand Madhao [1 ,2 ]
机构
[1] Indian Inst Technol Kharagpur, Dept Civil Engn, Kharagpur, W Bengal, India
[2] Indian Inst Technol Kharagpur, Sch Environm Sci & Engn, Kharagpur, W Bengal, India
关键词
Algal treatment; Beta-blockers; Constructed wetlands; Electro-oxidation; Emerging contaminants; Membrane technology; PERSONAL CARE PRODUCTS; ADVANCED OXIDATION PROCESSES; HETEROGENEOUS ELECTRO-FENTON; RECEPTOR-BLOCKING PHARMACEUTICALS; ENVIRONMENTAL RISK-ASSESSMENT; SEWAGE-TREATMENT PLANTS; EMERGING CONTAMINANTS; DAPHNIA-MAGNA; ELECTROCHEMICAL OXIDATION; MICROPOLLUTANT REMOVAL;
D O I
10.1007/s11356-021-18287-4
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The discharge of emerging pollutants, such as beta-blockers (BB), has been recognized as one of the major threats to the environment due to the ecotoxicity associated with these emerging pollutants. The BB are prescribed to treat high blood pressure and cardiovascular diseases; however, even at lower concentration, these pollutants can pose eco-toxic impacts towards aquatic organisms. Additionally, owing to their recalcitrant nature, BB are not effectively removed through conventional technologies, such as activated sludge process, trickling filter and moving bed bioreactor; thus, it is essential to understand the degradation mechanism of BB in established as well as embryonic technologies, like adsorption, electro-oxidation, Fenton process, ultraviolet-based advance oxidation process, ozonation, membrane systems, wetlands and algal treatment. In this regard, this review articulates the recalcitrant nature of BB and their associated removal technologies. Moreover, the major advantages and limitations of these BB removal technologies along with the recent advancements with regard to the application of innovative materials and strategies have also been elucidated. Therefore, the present review intends to aid the researchers in improving the BB removal efficiency of these technologies, thus alleviating the problem of the release of BB into the environment.
引用
收藏
页码:25427 / 25451
页数:25
相关论文
共 50 条
  • [21] Efficacy of Ivabradine in Combination with Beta-Blockers Versus Uptitration of Beta-Blockers in Patients with Stable Angina (CONTROL-2 Study)
    Glezer, Maria
    Vasyuk, Yuri
    Karpov, Yuri
    ADVANCES IN THERAPY, 2018, 35 (03) : 341 - 352
  • [22] Beta-Blockers in COPD: A Methodological Review of the Observational Studies
    Suissa, Samy
    Ernst, Pierre
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 15 (05) : 520 - 525
  • [23] Beta-blockers for the treatment of arrhythmias: Bisoprolol - a systematic review
    Muresan, L.
    Cismaru, G.
    Muresan, C.
    Rosu, R.
    Gusetu, G.
    Puiu, M.
    Mada, R. O.
    Martins, R. P.
    ANNALES PHARMACEUTIQUES FRANCAISES, 2022, 80 (05): : 617 - 634
  • [24] Antihypertensive Treatment with Beta-Blockers in the Metabolic Syndrome: A Review
    Carella, Angelo M.
    Antonucci, Giuseppe
    Conte, Matteo
    Di Pumpo, Michele
    Giancola, Armando
    Antonucci, Elisabetta
    CURRENT DIABETES REVIEWS, 2010, 6 (04) : 215 - 221
  • [25] A Review on the Putative Association Between Beta-Blockers and Depression
    Verbeek, Danielle E. P.
    van Riezen, Jerry
    de Boer, Rudolf A.
    van Melle, Joost P.
    de Jonge, Peter
    HEART FAILURE CLINICS, 2011, 7 (01) : 89 - +
  • [26] What is the Real Efficacy of Beta-Blockers for the Treatment of Essential Hypertension?
    Hocht, Christian
    Bertera, Facundo M.
    Del Mauro, Julieta S.
    Santander Plantamura, Yanina
    Taira, Carlos A.
    Polizio, Ariel H.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (31) : 4658 - 4677
  • [27] Efficacy of Different Beta-Blockers in the Treatment of Long QT Syndrome
    Abu-Zeitone, Abeer
    Peterson, Derick R.
    Polonsky, Bronislava
    McNitt, Scott
    Moss, Arthur J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (13) : 1352 - 1358
  • [28] EFFICACY OF TIOTROPIUM AND OLODATEROL COMBINATION IN PATIENTS WITH COPD ON beta-BLOCKERS
    Derom, E.
    Korn, S.
    Hamilton, A.
    Amatto, V. C.
    Zhao, Y.
    Maltais, F.
    THORAX, 2015, 70 : A142 - A142
  • [29] Added benefits from beta-blockers reported
    Aldridge, S
    LANCET, 1997, 349 (9049): : 407 - 407
  • [30] Topical beta-blockers in patients with co-existing conditions: is this a cause for concern?
    Good, CB
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (06) : 509 - 510